Edge Capital Group’s Gilead Sciences GILD Stock Holding History

Edge Capital Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$212K	Buy	+2,298	New	+$207K	0.01%	305
2023 Q2	–	Sell	-2,072	Closed	-$172K	–	350
2023 Q1	$172K	Sell	2,072 -193	-9%	-$16K	0.01%	306
2022 Q4	$194K	Sell	2,265 -55	-2%	-$4.36K	0.01%	287
2022 Q3	$143K	Buy	2,320 +199	+9%	+$12.5K	0.01%	292
2022 Q2	$131K	Buy	+2,121	New	+$131K	0.01%	292
2020 Q4	–	Sell	-4,870	Closed	-$308K	–	275
2020 Q3	$308K	Sell	4,870 -20,125	-81%	-$1.4M	0.03%	193
2020 Q2	$1.92M	Sell	24,995 -1,059	-4%	-$81.2K	0.2%	88
2020 Q1	$1.95M	Buy	+26,054	New	+$1.8M	0.23%	79

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edge Capital Group's GILD Position: Q4 2024 in Review

Edge Capital Group opened a new position in Gilead Sciences (GILD) in Q4 2024: 2,298 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #305 among its holdings. This is a return to the name: Edge Capital Group previously reported a position in GILD as recently as Q1 2023.

Edge Capital Group first reported a position in GILD in Q1 2020 and has held it in 8 quarters since. The position peaked at $1.95M in Q1 2020. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

Edge Capital Group held 2,298 shares of Gilead Sciences worth $212K as of Q4 2024.
Gilead Sciences was a new Edge Capital Group position in Q4 2024.
Gilead Sciences made up 0.01% of Edge Capital Group's portfolio in Q4 2024, its #305 holding.
Edge Capital Group first reported a position in Gilead Sciences in Q1 2020 and has held it in 8 quarters since.
Edge Capital Group's Gilead Sciences position peaked at $1.95M in Q1 2020.
1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Edge Capital Group's 13F filing for Q4 2024, filed 4 Feb 2025.